China News Service, April 23 (Chen Jing and Wang Guangzhao) Soft tissue sarcoma is a malignant tumor that is very easy to "resume". How to effectively cure it while avoiding the pain of "amputation" for patients is the goal of medical experts' continuous efforts.

  The reporter learned on the 23rd that medical experts in Shanghai innovatively adopted the new technology of "surgery + intraoperative radiotherapy" to successfully preserve limbs for patients, which greatly reduced the risk of recurrence.

  Professor Chen Yong, deputy director of the Department of Bone and Soft Tissue Surgery, Fudan University Tumor Hospital, said in an interview that day: “This type of treatment is to use radiotherapy equipment in the surgical treatment process to apply a single high dose at close range to tumor beds or residual lesions. Radiotherapy is conducive to improving the treatment effect, while reducing the damage caused by external radiotherapy and improving the quality of life of patients."

  The team successfully treated Mr. Tian, ​​a 60-year-old patient, with a comprehensive treatment of "surgery + intraoperative radiotherapy".

Mr. Tian suffered from soft tissue sarcoma repeatedly.

In 2021, Mr. Tian's tumor recurred again.

Since the recurring tumor is close to the vascular nerve bundle and close to the femur, he is likely to lose his left leg if he chooses extensive radical surgery.

Professor Chen Yong formulated the treatment plan of intraoperative radiotherapy for Mr. Tian.

  During the operation, Professor Chen Yong's team collaborated with radiotherapy, anesthesiologists, and operating room nursing teams to immediately use intraoperative radiotherapy equipment to "illuminate" the operating area after the fine tumor was removed.

  Professor Chen Yong introduced that soft tissue sarcoma is a malignant tumor that originates from connective tissue in all parts of the body except bone and cartilage.

There are many types of soft tissue sarcoma, of which limbs account for about 60%.

Surgery is the main method for the treatment of soft tissue sarcoma.

However, the risk of recurrence of soft tissue tumors is very high, especially when the tumor is adjacent to important nerves and blood vessels or internal organs, the risk of functional damage is high, which seriously affects the quality of life of patients.

  Chen Yong told reporters that his team successfully explored that intraoperative radiotherapy has added a new weapon to the comprehensive treatment of soft tissue sarcoma, which has very good clinical application value.

The doctor can irradiate the target area directly during the operation while avoiding the adjacent normal tissues and organs. Intraoperative radiotherapy can effectively improve the local control and better protect the function of the surrounding organs.

  During the interview, Chen Yong said frankly that, as a multidisciplinary cooperation technology, intraoperative radiotherapy requires the strict organization and precise cooperation of radiotherapists, physicists, surgeons, anesthesiologists, and nursing teams. There are very few domestic units that can develop this technology. The hospital stated that Professor Chen Yong took the lead in successfully carrying out intraoperative radiotherapy for soft tissue sarcoma in Shanghai, which will allow more patients to be expected to further increase the limb salvage rate and reduce the recurrence rate on the premise of radical cure of the tumor. (Finish)